Raymond R. Tjandrawinata

Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica

Executive Director

Tangerang

Indonesia

SCHOLARLY PAPERS

5

DOWNLOADS
Rank 21,316

SSRN RANKINGS

Top 21,316

in Total Papers Downloads

2,696

SSRN CITATIONS

0

CROSSREF CITATIONS

3

Scholarly Papers (5)

1.

The Impact of Mergers and Acquisitions in Research-Based Pharmaceutical Companies on Productivity

Number of pages: 20 Posted: 09 Jan 2012
Raymond R. Tjandrawinata and Destrina Grace Simanjuntak
Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica and Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group
Downloads 1,116 (22,163)
Citation 1

Abstract:

Loading...

mergers and acquisitions (M&A), R&D expenditure, sales revenue, R&D Intensity, total approval, new molecular entity

2.

Impact of Profitability, R&D Intensity, and Cash Flow on R&D Expenditure in Pharmaceutical Companies

Number of pages: 13 Posted: 05 May 2011
Destrina Grace Simanjuntak and Raymond R. Tjandrawinata
Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group and Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica
Downloads 662 (45,969)
Citation 4

Abstract:

Loading...

Research and Development Expenditure, Profitability, R&D Intensity, Cash Flow

3.

Factors Influencing Sales Revenue in the Multinational Pharmaceutical Companies

Number of pages: 13 Posted: 28 Jul 2011
Destrina Grace Simanjuntak and Raymond R. Tjandrawinata
Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group and Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica
Downloads 509 (64,286)

Abstract:

Loading...

sales revenue, profitability, R&D expenditure, marketing expenditure

4.

M&A of Generic Pharmaceutical Companies Increases Productivity

Number of pages: 13 Posted: 20 Oct 2011
Destrina Grace Simanjuntak and Raymond R. Tjandrawinata
Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group and Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica
Downloads 214 (167,130)

Abstract:

Loading...

M&A, R&D expenditure, profitability, R&D intensity, total approval, generic drug

5.

Sales Revenue Determinants for Generic Pharmaceutical Companies

Number of pages: 11 Posted: 26 Sep 2011
Destrina Grace Simanjuntak and Raymond R. Tjandrawinata
Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group and Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica
Downloads 195 (181,431)

Abstract:

Loading...

profitability, sales revenue, market share, new generic product, pharmaceutical generic companies